| __timestamp | Arrowhead Pharmaceuticals, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 152500000 |
| Thursday, January 1, 2015 | 57410147 | 187800000 |
| Friday, January 1, 2016 | 41454452 | 184000000 |
| Sunday, January 1, 2017 | 31690298 | 167700000 |
| Monday, January 1, 2018 | 52968505 | 218600000 |
| Tuesday, January 1, 2019 | 81048686 | 187400000 |
| Wednesday, January 1, 2020 | 128874979 | 177700000 |
| Friday, January 1, 2021 | 206342000 | 122000000 |
| Saturday, January 1, 2022 | 297307000 | 123100000 |
| Sunday, January 1, 2023 | 353188000 | 122500000 |
| Monday, January 1, 2024 | 505870000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Perrigo Company plc have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Arrowhead Pharmaceuticals has shown a remarkable increase in R&D spending, growing by over 2,000%. This surge underscores their aggressive pursuit of cutting-edge therapies and technologies. In contrast, Perrigo Company plc's R&D expenses have remained relatively stable, with a slight decline in recent years, reflecting a more conservative approach.
The data reveals a strategic divergence: Arrowhead's focus on innovation-driven growth versus Perrigo's steady, perhaps more risk-averse strategy. As we look to the future, these trends may shape the competitive dynamics in the pharmaceutical industry, influencing market leadership and technological advancements.
Comparing Innovation Spending: Novartis AG and Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Perrigo Company plc
Comparing Innovation Spending: GSK plc and Perrigo Company plc
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Perrigo Company plc
Comparing Innovation Spending: Neurocrine Biosciences, Inc. and Perrigo Company plc
Research and Development: Comparing Key Metrics for Intra-Cellular Therapies, Inc. and Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Jazz Pharmaceuticals plc and Perrigo Company plc
Amneal Pharmaceuticals, Inc. or Perrigo Company plc: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Perrigo Company plc vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: Perrigo Company plc vs Celldex Therapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Arrowhead Pharmaceuticals, Inc. vs Galapagos NV